File number: 28788
Sign in to comment.
By John S. King, MD
Retina Associates, PA
- Uploaded on Jan 9, 2019.
- Last modified by Caroline Bozell on Jan 10, 2019.
- Appears in
- SRH PPCNVM POHS Subretinal TPA
- presumed ocular histoplasmosis syndrome (POHS)
- Imaging device
- 76-year-old white male with history of treat/extend with Eylea OD for a PPCNVM; also monocular due to large scar in fellow eye. Two months since last injection, had acute decrease in vision OD and was seen that day. Vision CF; moderate SRH involving the fovea. Discussed monotherapy with anti-VEGF vs displacement, and elected for PPV, srTPA, AFx, SF6. Total of 0.2 cc of 25 microgram/0.1 ml of srTPA administered from two different areas in the temporal macula. This is the pre and post-op OCTs. The right image shows decreased SRF/H with improved foveal foveal contour.